David Baltimore

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit

GeneEditSummit

I just got back from a historic summit on human genetic modification in Washington, D.C. New genetic modification technology, termed CRISPR-Cas9, has both made genetic modification a relatively simple matter for scientists and human genetic modification much more likely in the near future. Heritable human genetic modification could prevent some rare genetic diseases so there …

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit Read More »

NAS Meeting on Human Germline Modification Taking Shape

NAS-CRISPR3

The US National Academy of Sciences (NAS) will hold a meeting on heritable human germline modification on December 1-3, 2015 in Washington, D.C. Invitations to the NAS meeting to individuals starting going out last week. The upcoming NAS meeting seeks to address these issues and discuss the possibility of a moratorium on clinical use of …

NAS Meeting on Human Germline Modification Taking Shape Read More »

Perspectives on Hinxton Human Germline Modification Statement

Hinxton-Group

The international stem cell policy and ethics think tank, the Hinxton Group, weighed in yesterday on heritable human genetic modification with a new policy statement. The Hinxton statement is in many ways in agreement with the Baltimore, et al. Nature paper proposing a “prudent path forward” for human germline genetic modification, which came out of …

Perspectives on Hinxton Human Germline Modification Statement Read More »

Why I Disagree with Steven Pinker On CRISPR

Steve-Pinker

Professor Steven Pinker of Harvard has been making the case recently that when it comes to novel biotechnologies such as CRISPR-Cas9 that bioethics should just get out of the way. Further, he has argued that we do not need a moratorium on clinical use of CRISPR-Cas9 for human genetic modification. In fact, he says that …

Why I Disagree with Steven Pinker On CRISPR Read More »

Steven Pinker interview: case against bioethocrats & CRISPR germline ban

Steven-Pinker

CRISPR-Cas9 gene editing technology is red-hot right now and I’ve been doing interviews with various thought leaders on it, which today includes Steven Pinker. This technology has great power for research in the lab and there are hypothetical transformative clinical applications of CRISPR too. The latter efforts could include experimental attempts at reversal of disease-causing …

Steven Pinker interview: case against bioethocrats & CRISPR germline ban Read More »

Hank Greely Human Germline Modification Post

Week-8-Cover

Hank Greely over at The Center for Law and Biosciences at Stanford Law School was one of the participants in the recent Napa meeting on approaches to human germline genetic modification. Hank was also one of the authors on the resulting position paper in Science with David Baltimore as first author (here). Now Hank, pictured below, …

Hank Greely Human Germline Modification Post Read More »

David Baltimore, et al. path for human germline engineering

human-germline-editing-policy

In a new perspectives piece in Science, Nobel Laureate David Baltimore and co-authors including Jennifer Doudna and George Church, chart a potential path forward for human germline engineering. See also accompanying Bioethics piece by Gretchen Vogel as well, “Embryo engineering alarm”. In the piece, entitled “A prudent path forward for genomic engineering and germline gene …

David Baltimore, et al. path for human germline engineering Read More »